Abstract
Congestive heart failure developed in a 42-year-old man who had very mild acromegalic features. Echocardiography showed a marked dilatation of the left ventricle and decreased systolic function. Laboratory examinations revealed the elevated levels of growth hormone and insulin-like growth factor-1 and pituitary microadenoma was demonstrated by magnetic resonance imaging. Although the extensive conventional medical treatment was ineffective, short-term addition of somatostatin analog, octreotide, rapidly improved his cardiac function. After discontinuation of octreotide, further improvement was observed with minimal residual diastolic dysfunction. All medical treatment could be stopped after successful trans-sphenoidal surgery. Early diagnosis and effective treatment is important to reverse the acromegalic cardiomyopathy.
Similar content being viewed by others
References
S Melmed (1990) ArticleTitleAcromegaly N Engl J Med 322 IssueID14 966–977 Occurrence Handle2179724 Occurrence Handle1:STN:280:DyaK3c7ptVyjsw%3D%3D Occurrence Handle10.1056/NEJM199004053221405
A Colao D Ferone P Marzullo G Lombardi (2004) ArticleTitleSystemic complications of acromegaly: epidemiology, pathogenesis, and management Endocr. Rev 25 IssueID1 102–152 Occurrence Handle14769829 Occurrence Handle10.1210/er.2002-0022 Occurrence Handle1:CAS:528:DC%2BD2cXhvFOmt7w%3D
KJ Osterziel MB Ranke O Strohm R Dietz (2000) ArticleTitleThe somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function Clin Endocrinol (Oxf) 53 IssueID1 61–68 Occurrence Handle10.1046/j.1365-2265.2000.01029.x Occurrence Handle1:CAS:528:DC%2BD3cXlvF2js7s%3D
F Broqlio A Fubini M Morello E Arvat G Aimaretti L Gianotti MF Boqhem R Deqhenqhi L Manqiardi E Ghiqo (1999) ArticleTitleActivity of GH/IGF-I axis in patients with dilated cardiomyopathy Clin Endocrinol (Oxf) 50 IssueID4 417–430 Occurrence Handle10.1046/j.1365-2265.1999.00696.x
J Oscarsson G Lindstedt PA Lundberg S Eden (1996) ArticleTitleContinuous subcutaneous infusion of low dose growth hormone decreases serum sex-hormone binding globulin and testosterone concentrations in moderately obese middle-aged men Clin Endocrinol (Oxf) 44 23–29 Occurrence Handle10.1046/j.1365-2265.1996.635457.x Occurrence Handle1:CAS:528:DyaK28XhtlymsLs%3D
SS Damjanovic AN Neskovic MS Petakov V Popovic B Vujisic M Petrovic M Nikolic-Djurrovic M Simic S Pekic J Marinkovic (2002) ArticleTitleHigh output heart failure in patients with newly diagnosed acromegaly Am J Med 112 IssueID8 610–616 Occurrence Handle12034409 Occurrence Handle10.1016/S0002-9343(02)01094-X
H Bihan C Espinosa H Valdes-Socin S Salenave J Young S Levasseur P Assayag A Beckers P Chanson (2004) ArticleTitleLong-term outcome of patients with acromegaly and congestive heart failure J Clin Endocrinol Metab 89 5308–5313 Occurrence Handle15531475 Occurrence Handle10.1210/jc.2004-0821 Occurrence Handle1:CAS:528:DC%2BD2cXhtVSisb7K
MP Matta P Caron (2003) ArticleTitleAcromegalic cardiomyopathy: a review of the literature Pituitary 6 IssueID4 203–207 Occurrence Handle15237931 Occurrence Handle10.1023/B:PITU.0000023427.31609.a2 Occurrence Handle1:CAS:528:DC%2BD2cXivFKmsr0%3D
P Chanson J Timsit C Masquet A Warnet PJ Guillausseau P Birman AG Harris J Lubetzki (1990) ArticleTitleCardiovascular effects of the somatostatin analog octreotide in acromegaly Ann Intern Med 113 921–925 Occurrence Handle2240917 Occurrence Handle1:STN:280:DyaK3M%2Flt1yisg%3D%3D
M Rishardson W McKenna M Briatow B Maisch B Mautner J O'Connell E Olsen G Thiene J Goodwin I Gvarfas I Martin P Nordet (1996) ArticleTitleThe 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies Circulation 93 841–842
JT Lie SJ Grossman (1980) ArticleTitlePathology of the heart in acromegaly: anatomic findings in 27 autopsied patients Am Heart J 100 41–52 Occurrence Handle6446234 Occurrence Handle10.1016/0002-8703(80)90277-X Occurrence Handle1:STN:280:DyaL3c3hslegsg%3D%3D
A Frustaci C Chimenti M Setoguchi S Guerra S Corsello F Crea A Leri J Kajstura P Anversa A Maseri (1999) ArticleTitleCell death in acromegalic cardiomyopathy Circulation 99 IssueID11 1426–1434 Occurrence Handle10086965 Occurrence Handle1:STN:280:DyaK1M7oslSqtQ%3D%3D
J Aono S Nobuoka J Nagashima S Hatano A Yoshida H Ando F Miyake M Murayama (1998) ArticleTitleHeart failure in 3 patients with acromegaly: echocardiographic assessment Intern Med 37 IssueID7 599–603 Occurrence Handle9711886 Occurrence Handle1:STN:280:DyaK1cznsFOjtg%3D%3D
P Chanson J Timsit AG Harris (1992) ArticleTitleHeart failure and octreotide in acromegaly Lancet 339 242–243 Occurrence Handle1346193 Occurrence Handle10.1016/0140-6736(92)90041-Z Occurrence Handle1:STN:280:DyaK387hsVGrtw%3D%3D
V Legrand A Beckers VT Pharm JC Demoulin A Stevenaert (1994) ArticleTitleDramatic improvement of severe dilated cardiomyopathy in an acromegalic patient after treatment with octreotide and trans-sphenoidal surgery Eur Heart J 15 1286–1289 Occurrence Handle7982434 Occurrence Handle1:STN:280:DyaK2M%2FntlClsg%3D%3D
M Nishiki Y Murakami M Sohmiya K Koshimura K Inoue Y Goto N Nakamura Y Kato (1997) ArticleTitleHistopathological improvement of acromegalic cardiomyopathy by intermittent subcutaneous infusion of octreotide Endocr J 44 IssueID5 655–660 Occurrence Handle9466320 Occurrence Handle1:STN:280:DyaK1c7isFOqtA%3D%3D
A Shimakura H Miyakoshi H Ohkuwa M Kitabayashi T Komai A Hisada K Aoki S Sakagami K Kobayashi S Takata (2002) ArticleTitleImprovement of cardiac function after treatment with octreotide followed by trans-sphenoidal surgery in an acromegalic patient who presented with congestive heart failure Jpn Heart J 43 IssueID1 69–77 Occurrence Handle12041892 Occurrence Handle10.1536/jhj.43.69
B Albat F Leclercq I Serre A Fille P Baldet R Grolleau-Raoux A Thevenet (1993) ArticleTitleHeart transplantation for terminal congestive heart failure in an acromegalic patient Eur Heart J 14 IssueID11 1572–1575 Occurrence Handle8299642 Occurrence Handle1:STN:280:DyaK2c7jtV2jtg%3D%3D
D Lattuada C Casnici A Venuto O Marelli (2002) ArticleTitleThe apoptotic effects of somatostatin analogue SMS 201–995 on human lymphocytes J Neuroimmunol 133 IssueID1–2 211–216 Occurrence Handle12446025 Occurrence Handle10.1016/S0165-5728(02)00364-8 Occurrence Handle1:CAS:528:DC%2BD38XoslantLk%3D
C Casnici D Lattuada P Franco L Cattaneo O Marelli (2004) ArticleTitleRegulation of human peripheral blood lymphocytes IL-10 by SMS 201–995 J Neuroimmunol 149 IssueID1–2 210–216 Occurrence Handle15020082 Occurrence Handle10.1016/j.jneuroim.2003.12.020 Occurrence Handle1:CAS:528:DC%2BD2cXitFChtbk%3D
NK Eryol M Guven R Topsukal M Sungur I Ozdogu T Inac A Oguzhan (2004) ArticleTitleThe effects of octreotide in dilated cardiomyopathy: an open-label trial in 12 patients Jpn Heart J 45 IssueID4 613–621 Occurrence Handle15353872 Occurrence Handle10.1536/jhj.45.613 Occurrence Handle1:CAS:528:DC%2BD2cXovVyksbk%3D
H Toshima (1995) ArticleTitleResearch on cardiomyopathy in Japan Heart Vessels 1 IssueIDSuppl 1 14–17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, MW., Shimatsu, A., Sasaki, Y. et al. Resolution of acromegalic cardiomyopathy in mild acromegalic physical abnormality after short-term octreotide therapy. Heart Vessels 22, 202–207 (2007). https://doi.org/10.1007/s00380-006-0960-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-006-0960-y